🚽 Happy #WorldToiletDay! Did you know the first flush toilet was invented in 1596 by Sir John Harington in #London? And in #Stockholm, the Källargränd urinoar is the city’s oldest public urinal. Love quirky urban history? Explore our #ScienceRallyes full of curious facts. 👉 www.sciencerallye.eu

Yesterday we held our final Steering Committee meeting! Our Coordinator summed it up perfectly: “The main focus now is how we can harvest, and produce, in the best possible way, until the end of TIMESPAN.” 🌱 Time to turn hard work into strong scientific outputs #ADHDResearch

Clinical data alone can’t capture how complex conditions evolve in daily life. In our latest blog post, empatica explores how continuous monitoring is transforming #digitalhealth research. Read more 👇 🔗 timespan.eu/continuous-m... #Wearables #RealWorldData #HealthResearch

What happens to women’s use of other medications when they start treatment for ADHD? Ms Dani Russell PhD research brings together data, lived experience, and a gendered lens to understand the unique experiences of women with #ADHD. See more on the blog: timespan.eu/women-adhd-d... #Neuroskyence

New research from @haskoliislands.bsky.social highlights an important link between #ADHD and #womenshealth. Using data from the Icelandic SAGA Cohort, the team found that women with ADHD experience more severe & earlier symptoms of #perimenopause. 👉 Read more: timespan.eu/adhd-perimen... #AdultADHD

@timespan-h2020.bsky.social Project Update: This year, TIMESPAN published work in Lancet Psychiatry and hosted a major public event on ADHD, obesity, and long-term health across Europe. Read more:

🚀 Highlights from the AADPA’s 8th Annual Conference on ADHD! Our team from Hong Kong Uni presented insights on early executive function development and community partnerships for children with #ADHD. Let’s advance ADHD care together! #HealthcareInnovation #CommunityEngagement

🧠💊 ADHD meds do more than treat symptoms. A new @bmj.com study from TIMESPAN partners at @ki.se shows reduced risks of suicide, substance misuse, transport accidents & criminality. Important evidence for clinical practice. 🔗 www.bmj.com/content/390/... #ADHD #ADHDsky #ADHDmedication #Neuroskyence

A really powerful listen 🎧 Our ART-CARMA study participant Christian shares his story of living with ADHD and receiving a diagnosis and beginning medication as an adult. Huge thanks to Christian for sharing his experience, and to Phoebe Rocks for supporting his involvement.

💬 “Once I understood my ADHD, and once I received acceptance instead of ongoing confusion, I was able to grow into a person I never thought I could be.” For #ADHDAwarenessMonth, Christian shares his powerful story. 🎧 Listen here 👉 youtu.be/9xCk7uUZeEQ @adhd-remote-tech.bsky.social #AdultADHD

The #ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence (ART-CARMA) team discuss their preliminary findings and attendance at the #EUNETHYDIS (the European Network for ADHD) 36th annual meeting. Read more: timespan.eu/adhd-art-car...

🎙 New TIMESPAN podcast episode! For #ADHDAwarenessMonth (The Many Faces of ADHD), we invited Viljo Wilding (ADDISS, ADHD Europe) to talk about why lived experience must shape #ADHD research + what science means for real lives. 👉 Listen: https://youtu.be/qHHatpMcM14  @viljo.me

🌍Going further - together😊 Multi-database #Pharmacoepidemiology unlocks insights no single dataset can: Rare outcomes, subgroup effects, local practice patterns. But it’s complex 10 steps to keep studies robust & reproducible: 👉 onlinelibrary.wiley.com/doi/10.1002/... #RealWorldData #MultiCountry

#PCOS is more than a reproductive disorder. 💡 Our latest blog explores how PCOS links to ADHD and cardiometabolic health. And why holistic care matters. 👉 Read the full post: timespan.eu/pcos-adhd-ca... #ADHD #CardiometabolicHealth #WomensHealth

Excited to share team @vhir.bsky.social's latest research addressing the question how polygenic risk for psychiatric disorders can show up in children’s behaviors & emotions. 👧🧬 Congrats to @silvialemany.bsky.social et al! 🔓 doi.org/10.1016/j.ja... #MentalHealth #ChildPsychiatry

👏 Huge congratulations to our partner Kelli Lehto (@klehto.bsky.social, Uni Tartu) on winning an ERC grant for Attention on Inattention: Dissecting the causal mechanisms of adult ADHD features! The project will aims to advance #adultADHD diagnosis. 🎉 #ERC

TIMESPAN member Stephen Faraone ( @upstatemedical.bsky.social) was recently interviewed by @zeit.de on ADHD. 🔗 Read our summary here: timespan.eu/newsroom/pro... 🔗 Read the full article by DIE ZEIT here (paywalled, German only): www.zeit.de/2025/33/neur... #ADHD #Neuroscience

At our TIMESPAN forum in London (with ADDISS & ADHD-Europe), we explored why so many with ADHD stop their medication from both research and lived experience perspectives. Here’s what participants told us 👇

From @timespan-h2020.bsky.social: Digital biomarkers can bring immense value in clinical research and healthcare by offering non-invasive, objective, and continuous measurements of physiological and behavioural parameters, collected via wearable sensors. Read more:

ADHD & Cardiometabolic Disease: What’s the connection? In this week’s blog, @easoobesity.bsky.social shares how TIMESPAN explores the overlap between #ADHD, #obesity & diabetes 👉 Read more: timespan.eu/adhd-cardiom... #Type2Diabetes

What does grassroots dissemination look like? TIMESPAN works closely with people with lived experiences & organisations to make research matter. Beyond papers and conferences. Read about our approach: 🔗 timespan.eu/timespan-gra... #ADHD #TIMESPAN #Scicomm

On #WorldBrainDay, we spotlight #ADHD, a brain condition with lifelong impact. TIMESPAN research reveals how it shapes risks for #obesity, #diabetes & heart disease.  More results coming soon. @easoobesity.bsky.social  #WBD2025

⌚What is the value of using digital endpoints in cardiometabolic disease monitoring? Read this blog post by empatica to understand some of their benefits, including personalized and immediate treatment, and supporting diverse populations. Read the full post: timespan.eu/digital-endp...

🚀 Global ADHD conferences updates! Recent conferences in Chongqing, Prague & Beijing advanced ADHD care worldwide. Key focus: ✅ Lived experience ✅ Global collaboration 🌍 Join the movement! Let's shape better #ADHDcare together: docs.google.com/forms/d/e/1F... 🤝 #ADHD

Can AI help build fairer, more accurate genetic models for ADHD? 🧠✨ New research from our @sunyofficial.bsky.social shows how adding biological context & removing ancestry bias can improve prediction. Now, they’re applying it to #ADHD. 🔗 Read more: timespan.eu/rethinking-a... #ADHDresearch #AI

EASO is part of a consortium of 17 partners worldwide, supporting the @timespan-h2020.bsky.social‬ project. The aim of the project is to improve clinical outcomes and quality of life in adult ADHD patients with co-occurring metabolic diseases. easo.org/timespan/

Hey, #ADHDcommunity! How do you find & consume information about #ADHD? Take our very short, anonymous survey 👉 docs.google.com/forms/d/e/1F... 🙏 Thank you!! Your input will help us improve how ADHD-related resources and research results are shared. #AdultADHD #ADHDresearch

Do #ADHDmedicines in pregnancy affect child mental development? Dr Claudia Bruno led a multinational Nordic study providing new evidence. Now she is enlarging the collaboration, adding Australian data. 🇳🇴🤝🇦🇺 Blog post: timespan.eu/adhd-medicat... #ADHDresearch #Pregnancy

We're introducing one of the key members of the ART team, @alicebarnes.bsky.social! As the ART-CARMA study coordinator and a PhD student, Alice ensures the study is running smoothly as well as conducts her own analyses. It's been amazing to see all of the exciting results from her hard work 🎉

New study alert! 🚨 "Sex differences in adults with #ADHD" reveals how symptoms manifest differently in men & women. Crucial for better diagnosis & treatment! Blog post: timespan.eu/sex-differen... Study: pubmed.ncbi.nlm.nih.gov/40211765/ #MentalHealth #Research

ADHD medication shortages are ongoing worldwide due to supply chain disruptions. If affected, speak with your healthcare provider about alternatives. Stay proactive for the best ADHD care! Read more: timespan.eu/adhd-medicat... By Andrew Yuen & @kennethkcman.bsky.social #ADHD #MedicationShortage

𝗢𝘂𝘁 𝗼𝗳 𝗙𝗼𝗰𝘂𝘀🔍 #Inattention isn’t just an #ADHD symptom - it’s a transdiagnostic risk factor. In a study of 80,000 adults, attention problems predicted lower satisfaction with work, health, relationships, and meaningfulness of life #MentalHealth 👉 Read the full blog: timespan.eu/out-of-focus...

KCL PhD student Alice Barnes shares her reflections on the 10th (but her first) #ADHD World Congress in Prague last week and presenting initial ART-CARMA data. Check out her blog post: timespan.eu/reflections-... @adhd-remote-tech.bsky.social @kingsioppn.bsky.social #ADHDresearch

🧵1/ TIMESPAN is at the #ADHDWorldCongress! Our members + advisors are presenting research on ADHD, heart health & treatment patterns. Here’s where to find us👇 #ADHD #TIMESPANproject #ADHDresearch www.adhd-congress.org/scientific-p...

Can’t sleep and have #ADHD? 😴 You’re not alone—and it’s not just about feeling tired. Poor #SleepHealth in ADHD may raise the risk of heart disease, diabetes & more. Sleep deserves more attention in ADHD care! 🔗Read more: timespan.eu/adhd-and-sle...

🧠 it's a wrap already! ▪️findings from TIMESPAN research ▪️panel discussion on stopping #ADHD meds ▪️ keynote on ADHD in our prisons: experiences of a prison counsellor Huge thank you to everyone for joining this first public engagement event 🙏 @adhd-remote-tech.bsky.social

The morning session of our event was so great already! ▪️Welcome by Phil Anderton, CEO of ADHD 360 ▪️ introduction ▪️ personal experience by alison lake, Helen Brumpton, & Henry Tierney ▪️ Findings & Panel discussion on the #ADHD and #obesity @easoobesity.bsky.social @ecpobesity.bsky.social

🧠 From epidemiology to AI Day 2 of our #TIMESPAN GA covered research updates, remote monitoring, and predictive modelling. On to tomorrow’s Public Engagement Event! 🚀 #ADHD #CardiometabolicHealth #HorizonEU

Hi from London! 👋🎡 Our 5th GA day 1 just finished. 👉masterclass (Dr Folarin & @alicebarnes.bsky.social on @adhd-remote-tech.bsky.social 👉keynote lecture by Prof. Dobson 👉Flash talks by our ECS! We're off to @sciencerallye.bsky.social now #younginvestigator #pharmacoepi #mhealth #adhdresearch

🧠✨Just 4 days to go until our public engagement event — and we’re thrilled to announce that the day will be moderated by Phil Anderton, PhD, CEO of #ADHD360! With 20+ years of experience in the #ADHD field, Phil brings valuable insight and steady guidance to the day.

⏳ 1 week | Join Our Public Engagement Event 👉 Insights into #ADHD, #obesity & cardiometabolic health 📅/📍? April 11, 2025, The Abbey Centre, London 🔗 Be quick. We'll close registration today docs.google.com/forms/d/e/1F... More info: timespan.eu/patient-event/ #ADHDresearch #publicevent

Of course, 'tis a must - the project session! 🧠 ◽ Connection between #ADHD, #HeartHealth & Medication ◽ How Do People Use #ADHDMedication? ◽ Genetics Behind ADHD Medication Use ◽ Predicting Health Risks in ADHD #AI ◽ What Can Wearable Tech Tell About ADHD & Health? @adhd-remote-tech.bsky.social

Big step for ADHD research! 🚀 TIMESPAN is now part of @ema.europa.eu's EMA Catalogue of Real-World Data—a move towards more transparency & better research standards in pharmacoepidemiology. Learn more 👉 timespan.eu/timespan-joi... #Realworlddata #Pharmacoepidemiology #ADHD

📣 Keynote at Public Event: Sarah Templeton, CEO of #ADHDLiberty, will share her experiences as a prison counsellor working with offenders who have undiagnosed or untreated #ADHD. She'll highlight the role of medication & challenges in accessing treatment. 👉Register: docs.google.com/forms/d/e/1F...

On April 11th, we'll focus on #ADHD & #obesity. Both often coexist, but how do these conditions influence each other? @viljo.me, Andrea Bilbow, Antoni Ramos-Quiroga, Alison Lake & @jasoncghalford.bsky.social will discuss this and more. @ecpobesity.bsky.social @easoobesity.bsky.social

🔔 2 Weeks to Go! Join Us at TIMESPAN's Public Engagement Event What? #ADHD, #obesity & cardiometabolic health research When/where? April 11, 2025, The Abbey Centre, London, UK 🔗 Register docs.google.com/forms/d/e/1F... @easoobesity.bsky.social @ecpobesity.bsky.social @adhd-remote-tech.bsky.social

This week ART-CARMA saw its 150th study participant finished their 12-month remote monitoring period, with 78 having now completed their study duration in UK with our @kingscollegelondon.bsky.social team and 76 in Spain with team at the VHIR!

TIMESPAN is proud to hear the voices of people with #livedexperience at our Public Event (11 April, London)! Helen Brumpton, Alison Lake of @ecpobesity.bsky.social, and Henry Tierney will share their personal stories and journeys with #ADHD & a co-occurring cardiometabolic disease.

Behind the Scenes of a Public Engagement Event in #ADHD ✅ Designed with patients & researchers in mind ✅ A welcoming & accessible venue ✅ Real conversations beyond just data 📍 Join us in London & register: docs.google.com/forms/d/e/1F... @adhd-remote-tech.bsky.social @easoobesity.bsky.social

Many individuals with #ADHD start medication but stop taking it over time. Why? We'll discuss this question in a dedicated session at our Public Engagement Event on 11 April 2025 in London! Register here: docs.google.com/forms/d/e/1F... #pharmacoepi @adhd-remote-tech.bsky.social @viljo.me